Dr. François Blaudeau, The first to file Power Morcellator Cancer Lawsuits Alleging The Laparoscopic Hysterectomy Spread Undetected Uterine Cancer.
Dr. François Blaudeau is currently representing numerous women and their spouses in power morcellator cancer lawsuit claims. The firm has developed and will maintain a new Facebook page to provide postings on the legal issues and other information surrounding laparoscopic power morcellators. Court doucments contend that Johnson & Johnson new about the uterine cancer risks that have been purportedly associated with power morcellation. Infact, documents purport that women who have had hysterectomies or myomectomies using a power morcellator have have developed uterin cancer, have had undetected cancer cells spread, and have even died from metastatic leiomyosarcoma after uterine morcellation, which is a rare and aggressive form of uterine cancer,
The firm hopes the new Facebok page, entitled Power Morcellator Cancer Information will provide current and detailed information, where visitors can post comments about their experiences, and ask questions regarding their legal rights. The social media site is another effort by Dr. Blaudeau and Southern Med Law Firm to keep their clients and the public informed about the rising litigation and latest development regarding the controversial power morcellation hysterectomy procedure that is currently being investigated by the FBI.
“Facebook is a popular social media site and we believe this is yet another way of disseminating important information involving power morcellation and the allegations of severe injuries and death in women associated with the medical device.” – Southern Med Law
Southern Med Law’s Facebook page will also include updated postings of the FBI’s investigation into laparoscopic power morcellators due to their cancer risks, the subject of an article that was recently featured on the law firm’s website. The law firm reviewed a Wall Street Journal report on the federal probe that will include an examination of Johnson & Johnson’s Ethicon unit, which halted sales of its power morcellators after the U.S. Food and Drug Administration (FDA) issued a warning about the cancer risks linked with the surgical instrument.
As stated in court records and the FDA, laparoscopic power morcellators are electronic surgical devices that are used in hysterectomies (removal of the uterus) and myomectomies (removal of uterine fibroids). According to the FDA, power morcellators grind up uterine tissue into fragments to be removed through a small incision in the abdomen. The undetected cancer cells spread as the uterine tissue is removed through the abdomen, the federal agency says. An FDA analysis shows that the prevalence of unsuspected cancer in women having a hysterectomy or myomectomy for presumed benign leiomyoma is 1 in 352 and the prevalence of unsuspected uterine leiomyosarcoma is 1 in 498.
The firm notes that the FDA issued a safety alert in November 2014 that strongly warned against using laparoscopic power morcellators in the vast majority of women who required a hysterectomy and myomectomy. While the FDA did not ban the use of the surgical tool, the federal agency ordered morcellator manufacturers to place black box warnings on their labels. The law firm adds that earlier in 2014, the federal regulatory agency discouraged surgeons from using the morcellators because of their risks of spreading unsuspected cancer cells beyond the uterus.
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm, April 17, 2014]
Court documents indicate that Southern Med Law’s Founder, Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, is on the forefront of power morcellation cancer lawsuits, having filed the first morcellation lawsuit in the United States against morcellator manufacturers LiNa Medical US d/b/a LiNA Medical, Blue Endo and Ethicon Inc. The morcellation complaint involves a Pennsylvania woman who died in February 2013 of metastatic leiomyosarcoma, a rare and aggressive form of uterine cancer, after undergoing a minimally-invasive hysterectomy in March 2012. The morcellation lawsuit contends that the morcellation manufacturers knew of this risk, bur concealed the danger from U.S. health regulators and the medical community. (Case No. 5:14-cv-1557, U.S. District Court, Eastern District of Pennsylvania) Dr. Blaudeau is serving as lead counsel in this case and is also working with Co-Counsel Andy Alonso of Alonso Krangle LLP Law Firm in New York on the case of New York resident Brenda Leuzzi who died two years after undergoing a Robot-assisted hysterectomy with uterine morcellation in 2012. (Case No. 6:14-cv-06218, U.S. District Court, Western District of New York).
About Southern Med Law
Southern Med Law is a patient and consumer advocacy organization providing legal representation to the victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.
Southern Med Law
Southern Institute for Medical and Legal Affairs
2224 1st Ave., North
Birmingham, AL 35203
Phone: (205) 547-5525
Fax: (205) 547-5526